Clinical Trial Update: Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the safety and efficacy of Lyrica (pregabalin) for newly diagnosed partial epilepsy has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy Partial

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsy, Partial | Phase 3 | Status: COMPLETED | Results posted: 2011-10-24